Back to discover
Drug

Baclofen

In clinical development
ClassGABA-B receptor agonistEmerging researchLate-stage developmentSteady momentum
Also known as 4-Amino-3-(4-chlorophenyl)butyric acid, Fleqsuvy, Gablofen, Lioresal+10 more

4-Amino-3-(4-chlorophenyl)butyric acid, Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax, beta-(4-Chlorophenyl)gaba, beta-(Aminomethyl)-4-chlorobenzenepropanoic acid, beta-(Aminomethyl)-p-chlorohydrocinnamic acid, beta-(p-Chlorophenyl)-gamma-aminobutyric acid, gamma-Amino-beta-(p-chlorophenyl)butyric acid, Baclofeno, Baclofène, Baclofenum.

4
Research papers
5
Active clinical trials
2
Protein targets
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Clinical trial2026-05-13Results expected Q4 2030 · ClinicalTrials.gov

Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence

Clinical trial2026-05-11Results expected Q4 2028 · ClinicalTrials.gov

Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve

Clinical trial2025-08-28Primary completion · ClinicalTrials.gov

Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.

Clinical trial2025-03-31Primary completion · ClinicalTrials.gov

A human laboratory pilot study with baclofen in alcoholic individuals.

Research2012-12-19Pharmacology, biochemistry, and behavior

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Baclofen
Aliases & brands
4-Amino-3-(4-chlorophenyl)butyric acidFleqsuvyGablofenLioresalLyvispahOzobaxbeta-(4-Chlorophenyl)gababeta-(Aminomethyl)-4-chlorobenzenepropanoic acidbeta-(Aminomethyl)-p-chlorohydrocinnamic acidbeta-(p-Chlorophenyl)-gamma-aminobutyric acidgamma-Amino-beta-(p-chlorophenyl)butyric acidBaclofenoBaclofèneBaclofenum
RxNorm CUI
1292
ChEMBL ID
CHEMBL701
ATC codes
M03BX01
UNII
H789N3FKE8
Primary mechanism
GABA-B receptor agonist

Pharmacology & targets

2 targets

Known molecular targets and mechanisms supported by curated pharmacology databases.

AGONISTGABA-B receptor agonist
AGONISTGABA-B receptor agonist

Clinical trials

70 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
70
registered trials across all phases
LATEST COMPLETION 2025
5
Active studies
3
Recruiting
40
Late-stage (III+)
46
Completed
19
Discontinued
PHASE DISTRIBUTIONn = 70
Early Phase 14Phase 16Phase 1 / 23Phase 217Phase 2 / 38Phase 37Phase 415Phase N / A10

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

4 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20132022
Most influential
Recent papers
Major research themes3
Alcoholics1Opioid-Related Disorders1Survivors1
Journals, researchers & institutions
Top journals
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
  • Pharmacology, biochemistry, and behavior1
  • Translational psychiatry1
  • Trials1
Leading researchers
  • Leggio L2
  • Addolorato G1
  • Amodio JP1
  • Bak K1
  • Barker D1
  • Bleeker J1
  • Bollinger JW1
  • Cavaletti G1
Leading institutions
free-text, unnormalised
  • Center for Alcohol and Addiction Studies2
  • Clinical Center Nursing Department1
  • Columbia University Medical Center1
  • Imperial Clinical Trials Unit1
  • Imperial College London1
  • Office of the Clinical Director1

Related drugs

5 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 3 of the same disease areas as Baclofen in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Baclofen in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Baclofen in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Baclofen in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Baclofen in the shared literature.

3 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials